nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—NR1I2—obesity	0.305	0.853	CbGaD
Erlotinib—ORM1—Bupropion—obesity	0.0721	0.22	CbGbCtD
Erlotinib—ALB—obesity	0.0527	0.147	CbGaD
Erlotinib—CYP2C8—Bupropion—obesity	0.0234	0.0715	CbGbCtD
Erlotinib—CYP1A2—Phentermine—obesity	0.0213	0.0651	CbGbCtD
Erlotinib—CYP1A2—Phenylpropanolamine—obesity	0.0204	0.0621	CbGbCtD
Erlotinib—CYP1A2—Bupropion—obesity	0.0182	0.0554	CbGbCtD
Erlotinib—CYP3A5—Cimetidine—obesity	0.0179	0.0546	CbGbCtD
Erlotinib—CYP2D6—Phentermine—obesity	0.0176	0.0536	CbGbCtD
Erlotinib—CYP2C8—Cimetidine—obesity	0.0172	0.0525	CbGbCtD
Erlotinib—CYP2D6—Bupropion—obesity	0.015	0.0456	CbGbCtD
Erlotinib—CYP3A4—Sibutramine—obesity	0.0148	0.045	CbGbCtD
Erlotinib—CYP2D6—Methamphetamine—obesity	0.0141	0.0429	CbGbCtD
Erlotinib—CYP1A2—Cimetidine—obesity	0.0133	0.0406	CbGbCtD
Erlotinib—ABCB1—Cimetidine—obesity	0.0117	0.0355	CbGbCtD
Erlotinib—CYP3A4—Benzphetamine—obesity	0.0112	0.0341	CbGbCtD
Erlotinib—CYP2D6—Cimetidine—obesity	0.011	0.0335	CbGbCtD
Erlotinib—CYP3A4—Bupropion—obesity	0.00951	0.029	CbGbCtD
Erlotinib—CYP3A4—Orlistat—obesity	0.00775	0.0236	CbGbCtD
Erlotinib—CYP3A4—Cimetidine—obesity	0.00698	0.0213	CbGbCtD
Erlotinib—CYP3A4—Topiramate—obesity	0.00457	0.0139	CbGbCtD
Erlotinib—ORM1—bile—obesity	0.00311	0.0447	CbGeAlD
Erlotinib—MAP3K19—respiratory system—obesity	0.00127	0.0183	CbGeAlD
Erlotinib—NR1I2—digestive system—obesity	0.00111	0.016	CbGeAlD
Erlotinib—FLT3—respiratory system—obesity	0.0011	0.0159	CbGeAlD
Erlotinib—MAP2K5—hindbrain—obesity	0.00108	0.0155	CbGeAlD
Erlotinib—PIP4K2C—islet of Langerhans—obesity	0.00105	0.0152	CbGeAlD
Erlotinib—JAK3—adipose tissue—obesity	0.000942	0.0136	CbGeAlD
Erlotinib—HIPK4—endocrine gland—obesity	0.000927	0.0134	CbGeAlD
Erlotinib—NR1I2—endocrine gland—obesity	0.000917	0.0132	CbGeAlD
Erlotinib—AURKC—adrenal gland—obesity	0.000913	0.0132	CbGeAlD
Erlotinib—SLK—islet of Langerhans—obesity	0.000896	0.0129	CbGeAlD
Erlotinib—JAK3—digestive system—obesity	0.000887	0.0128	CbGeAlD
Erlotinib—TNK1—pituitary gland—obesity	0.000869	0.0125	CbGeAlD
Erlotinib—ORM1—gall bladder—obesity	0.000862	0.0124	CbGeAlD
Erlotinib—JAK3—adrenal gland—obesity	0.000845	0.0122	CbGeAlD
Erlotinib—FLT3—cardiovascular system—obesity	0.000843	0.0121	CbGeAlD
Erlotinib—PIP4K2C—adrenal cortex—obesity	0.000835	0.012	CbGeAlD
Erlotinib—ABL1—hindbrain—obesity	0.00083	0.012	CbGeAlD
Erlotinib—NR1I2—liver—obesity	0.000827	0.0119	CbGeAlD
Erlotinib—ULK3—adrenal cortex—obesity	0.000797	0.0115	CbGeAlD
Erlotinib—AURKC—endocrine gland—obesity	0.000792	0.0114	CbGeAlD
Erlotinib—TNK1—adrenal gland—obesity	0.000776	0.0112	CbGeAlD
Erlotinib—ALB—gall bladder—obesity	0.000756	0.0109	CbGeAlD
Erlotinib—MKNK1—adrenal cortex—obesity	0.00075	0.0108	CbGeAlD
Erlotinib—STK10—respiratory system—obesity	0.000736	0.0106	CbGeAlD
Erlotinib—JAK3—endocrine gland—obesity	0.000733	0.0106	CbGeAlD
Erlotinib—EPHA6—endocrine gland—obesity	0.000733	0.0106	CbGeAlD
Erlotinib—ABL2—pituitary gland—obesity	0.000713	0.0103	CbGeAlD
Erlotinib—SLK—adrenal cortex—obesity	0.00071	0.0102	CbGeAlD
Erlotinib—ABL2—adipose tissue—obesity	0.00071	0.0102	CbGeAlD
Erlotinib—EGFR—adipose tissue—obesity	0.000693	0.00998	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—obesity	0.000684	0.00986	CbGeAlD
Erlotinib—PIP4K2C—pituitary gland—obesity	0.000674	0.00972	CbGeAlD
Erlotinib—TNK1—endocrine gland—obesity	0.000673	0.0097	CbGeAlD
Erlotinib—PIP4K2C—adipose tissue—obesity	0.000672	0.00968	CbGeAlD
Erlotinib—FLT3—adrenal gland—obesity	0.000667	0.00961	CbGeAlD
Erlotinib—ULK3—pituitary gland—obesity	0.000644	0.00928	CbGeAlD
Erlotinib—ULK3—adipose tissue—obesity	0.000641	0.00924	CbGeAlD
Erlotinib—ABL2—adrenal gland—obesity	0.000637	0.00917	CbGeAlD
Erlotinib—EGFR—adrenal gland—obesity	0.000621	0.00895	CbGeAlD
Erlotinib—TNK1—liver—obesity	0.000607	0.00874	CbGeAlD
Erlotinib—MKNK1—pituitary gland—obesity	0.000606	0.00873	CbGeAlD
Erlotinib—ULK3—digestive system—obesity	0.000604	0.0087	CbGeAlD
Erlotinib—MKNK1—adipose tissue—obesity	0.000604	0.0087	CbGeAlD
Erlotinib—PIP4K2C—adrenal gland—obesity	0.000602	0.00868	CbGeAlD
Erlotinib—FLT3—endocrine gland—obesity	0.000578	0.00833	CbGeAlD
Erlotinib—ULK3—adrenal gland—obesity	0.000575	0.00829	CbGeAlD
Erlotinib—SLK—pituitary gland—obesity	0.000574	0.00827	CbGeAlD
Erlotinib—SLK—adipose tissue—obesity	0.000572	0.00824	CbGeAlD
Erlotinib—MKNK1—digestive system—obesity	0.000568	0.00819	CbGeAlD
Erlotinib—STK10—cardiovascular system—obesity	0.000564	0.00812	CbGeAlD
Erlotinib—MAP2K5—adrenal cortex—obesity	0.000552	0.00795	CbGeAlD
Erlotinib—MKNK1—adrenal gland—obesity	0.000541	0.0078	CbGeAlD
Erlotinib—ABL1—islet of Langerhans—obesity	0.000537	0.00774	CbGeAlD
Erlotinib—PIP4K2C—endocrine gland—obesity	0.000522	0.00753	CbGeAlD
Erlotinib—FLT3—liver—obesity	0.000521	0.00751	CbGeAlD
Erlotinib—SLK—adrenal gland—obesity	0.000513	0.00739	CbGeAlD
Erlotinib—SLCO2B1—respiratory system—obesity	0.000511	0.00737	CbGeAlD
Erlotinib—ABL1—respiratory system—obesity	0.000507	0.0073	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—obesity	0.000503	0.00725	CbGeAlD
Erlotinib—ULK3—endocrine gland—obesity	0.000499	0.00719	CbGeAlD
Erlotinib—ABL2—liver—obesity	0.000498	0.00717	CbGeAlD
Erlotinib—STK10—adipose tissue—obesity	0.000497	0.00716	CbGeAlD
Erlotinib—EGFR—liver—obesity	0.000486	0.007	CbGeAlD
Erlotinib—PIP4K2C—liver—obesity	0.000471	0.00679	CbGeAlD
Erlotinib—MKNK1—endocrine gland—obesity	0.000469	0.00676	CbGeAlD
Erlotinib—STK10—digestive system—obesity	0.000468	0.00674	CbGeAlD
Erlotinib—ULK3—liver—obesity	0.00045	0.00648	CbGeAlD
Erlotinib—STK10—adrenal gland—obesity	0.000446	0.00642	CbGeAlD
Erlotinib—MAP2K5—pituitary gland—obesity	0.000446	0.00642	CbGeAlD
Erlotinib—MAP2K5—adipose tissue—obesity	0.000444	0.00639	CbGeAlD
Erlotinib—UGT1A1—digestive system—obesity	0.000442	0.00637	CbGeAlD
Erlotinib—CYP1B1—respiratory system—obesity	0.000429	0.00619	CbGeAlD
Erlotinib—ABL1—adrenal cortex—obesity	0.000425	0.00613	CbGeAlD
Erlotinib—MKNK1—liver—obesity	0.000423	0.0061	CbGeAlD
Erlotinib—SLK—liver—obesity	0.000401	0.00578	CbGeAlD
Erlotinib—MAP2K5—adrenal gland—obesity	0.000398	0.00574	CbGeAlD
Erlotinib—ABL1—cardiovascular system—obesity	0.000388	0.00559	CbGeAlD
Erlotinib—STK10—endocrine gland—obesity	0.000387	0.00557	CbGeAlD
Erlotinib—UGT1A1—endocrine gland—obesity	0.000365	0.00526	CbGeAlD
Erlotinib—CYP2D6—hindbrain—obesity	0.000359	0.00517	CbGeAlD
Erlotinib—STK10—liver—obesity	0.000349	0.00502	CbGeAlD
Erlotinib—SLCO2B1—adipose tissue—obesity	0.000345	0.00498	CbGeAlD
Erlotinib—MAP2K5—endocrine gland—obesity	0.000345	0.00497	CbGeAlD
Erlotinib—ABL1—pituitary gland—obesity	0.000344	0.00495	CbGeAlD
Erlotinib—ABL1—adipose tissue—obesity	0.000342	0.00493	CbGeAlD
Erlotinib—UGT1A1—liver—obesity	0.000329	0.00474	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—obesity	0.000329	0.00474	CbGeAlD
Erlotinib—SLCO2B1—digestive system—obesity	0.000325	0.00468	CbGeAlD
Erlotinib—ABL1—digestive system—obesity	0.000322	0.00464	CbGeAlD
Erlotinib—CYP3A5—islet of Langerhans—obesity	0.000314	0.00453	CbGeAlD
Erlotinib—MAP2K5—liver—obesity	0.000311	0.00448	CbGeAlD
Erlotinib—SLCO2B1—adrenal gland—obesity	0.00031	0.00446	CbGeAlD
Erlotinib—CYP1A2—respiratory system—obesity	0.000308	0.00443	CbGeAlD
Erlotinib—ABL1—adrenal gland—obesity	0.000307	0.00443	CbGeAlD
Erlotinib—CYP1A1—respiratory system—obesity	0.000304	0.00437	CbGeAlD
Erlotinib—CYP3A5—respiratory system—obesity	0.000297	0.00428	CbGeAlD
Erlotinib—CYP1B1—pituitary gland—obesity	0.000291	0.0042	CbGeAlD
Erlotinib—CYP1B1—adipose tissue—obesity	0.00029	0.00418	CbGeAlD
Erlotinib—Hepatobiliary disease—Orlistat—obesity	0.000287	0.00244	CcSEcCtD
Erlotinib—Stomatitis—Sibutramine—obesity	0.000286	0.00243	CcSEcCtD
Erlotinib—Conjunctivitis—Sibutramine—obesity	0.000285	0.00243	CcSEcCtD
Erlotinib—Melaena—Topiramate—obesity	0.000285	0.00242	CcSEcCtD
Erlotinib—ALB—adrenal gland—obesity	0.000283	0.00408	CbGeAlD
Erlotinib—Pancreatitis—Bupropion—obesity	0.000281	0.00239	CcSEcCtD
Erlotinib—Vomiting—Phenylpropanolamine—obesity	0.000281	0.00239	CcSEcCtD
Erlotinib—ORM1—endocrine gland—obesity	0.00028	0.00404	CbGeAlD
Erlotinib—Dizziness—Phentermine—obesity	0.00028	0.00238	CcSEcCtD
Erlotinib—Rash—Phenylpropanolamine—obesity	0.000279	0.00237	CcSEcCtD
Erlotinib—Dermatitis—Phenylpropanolamine—obesity	0.000279	0.00237	CcSEcCtD
Erlotinib—Body temperature increased—Cimetidine—obesity	0.000277	0.00236	CcSEcCtD
Erlotinib—Epistaxis—Sibutramine—obesity	0.000277	0.00236	CcSEcCtD
Erlotinib—Haemoglobin—Orlistat—obesity	0.000274	0.00233	CcSEcCtD
Erlotinib—Neuropathy—Topiramate—obesity	0.000274	0.00233	CcSEcCtD
Erlotinib—CYP1B1—digestive system—obesity	0.000273	0.00393	CbGeAlD
Erlotinib—Hepatitis—Orlistat—obesity	0.000272	0.00232	CcSEcCtD
Erlotinib—Haemorrhage—Orlistat—obesity	0.000272	0.00232	CcSEcCtD
Erlotinib—Dry eye—Topiramate—obesity	0.000269	0.00229	CcSEcCtD
Erlotinib—Vomiting—Phentermine—obesity	0.000269	0.00229	CcSEcCtD
Erlotinib—Urinary tract disorder—Orlistat—obesity	0.000269	0.00229	CcSEcCtD
Erlotinib—SLCO2B1—endocrine gland—obesity	0.000269	0.00387	CbGeAlD
Erlotinib—ABCG2—adrenal cortex—obesity	0.000268	0.00387	CbGeAlD
Erlotinib—Urethral disorder—Orlistat—obesity	0.000267	0.00227	CcSEcCtD
Erlotinib—Rash—Phentermine—obesity	0.000267	0.00227	CcSEcCtD
Erlotinib—Dermatitis—Phentermine—obesity	0.000267	0.00227	CcSEcCtD
Erlotinib—ABL1—endocrine gland—obesity	0.000266	0.00384	CbGeAlD
Erlotinib—Headache—Phentermine—obesity	0.000265	0.00226	CcSEcCtD
Erlotinib—Haemoglobin—Sibutramine—obesity	0.000265	0.00225	CcSEcCtD
Erlotinib—Haemorrhage—Sibutramine—obesity	0.000263	0.00224	CcSEcCtD
Erlotinib—Nausea—Phenylpropanolamine—obesity	0.000263	0.00224	CcSEcCtD
Erlotinib—CYP1B1—adrenal gland—obesity	0.00026	0.00375	CbGeAlD
Erlotinib—Weight decreased—Bupropion—obesity	0.00026	0.00221	CcSEcCtD
Erlotinib—Pneumonia—Bupropion—obesity	0.000257	0.00219	CcSEcCtD
Erlotinib—Infestation—Bupropion—obesity	0.000256	0.00218	CcSEcCtD
Erlotinib—Infestation NOS—Bupropion—obesity	0.000256	0.00218	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Bupropion—obesity	0.000254	0.00216	CcSEcCtD
Erlotinib—ORM1—liver—obesity	0.000253	0.00364	CbGeAlD
Erlotinib—Acute coronary syndrome—Bupropion—obesity	0.000252	0.00215	CcSEcCtD
Erlotinib—Diarrhoea—Diethylpropion—obesity	0.000252	0.00214	CcSEcCtD
Erlotinib—Nausea—Phentermine—obesity	0.000251	0.00214	CcSEcCtD
Erlotinib—Asthenia—Cimetidine—obesity	0.000251	0.00214	CcSEcCtD
Erlotinib—Neuropathy peripheral—Bupropion—obesity	0.000251	0.00213	CcSEcCtD
Erlotinib—Myocardial infarction—Bupropion—obesity	0.000251	0.00213	CcSEcCtD
Erlotinib—Stomatitis—Bupropion—obesity	0.000249	0.00212	CcSEcCtD
Erlotinib—Conjunctivitis—Bupropion—obesity	0.000249	0.00212	CcSEcCtD
Erlotinib—Eye disorder—Sibutramine—obesity	0.000246	0.0021	CcSEcCtD
Erlotinib—Mediastinal disorder—Orlistat—obesity	0.000245	0.00209	CcSEcCtD
Erlotinib—Dizziness—Diethylpropion—obesity	0.000243	0.00207	CcSEcCtD
Erlotinib—SLCO2B1—liver—obesity	0.000242	0.00349	CbGeAlD
Erlotinib—Epistaxis—Bupropion—obesity	0.000241	0.00205	CcSEcCtD
Erlotinib—Alopecia—Orlistat—obesity	0.00024	0.00205	CcSEcCtD
Erlotinib—ABL1—liver—obesity	0.00024	0.00346	CbGeAlD
Erlotinib—Diarrhoea—Cimetidine—obesity	0.00024	0.00204	CcSEcCtD
Erlotinib—Mental disorder—Orlistat—obesity	0.000238	0.00203	CcSEcCtD
Erlotinib—Malnutrition—Orlistat—obesity	0.000237	0.00202	CcSEcCtD
Erlotinib—Chills—Sibutramine—obesity	0.000236	0.00201	CcSEcCtD
Erlotinib—Hepatic failure—Topiramate—obesity	0.000235	0.002	CcSEcCtD
Erlotinib—Arrhythmia—Sibutramine—obesity	0.000235	0.002	CcSEcCtD
Erlotinib—Vomiting—Diethylpropion—obesity	0.000234	0.00199	CcSEcCtD
Erlotinib—Flatulence—Orlistat—obesity	0.000233	0.00199	CcSEcCtD
Erlotinib—Alopecia—Sibutramine—obesity	0.000233	0.00198	CcSEcCtD
Erlotinib—Rash—Diethylpropion—obesity	0.000232	0.00198	CcSEcCtD
Erlotinib—Dermatitis—Diethylpropion—obesity	0.000232	0.00197	CcSEcCtD
Erlotinib—Dizziness—Cimetidine—obesity	0.000232	0.00197	CcSEcCtD
Erlotinib—Haemoglobin—Bupropion—obesity	0.000231	0.00196	CcSEcCtD
Erlotinib—Headache—Diethylpropion—obesity	0.000231	0.00196	CcSEcCtD
Erlotinib—Haemorrhage—Bupropion—obesity	0.00023	0.00195	CcSEcCtD
Erlotinib—Hepatitis—Bupropion—obesity	0.00023	0.00195	CcSEcCtD
Erlotinib—Malnutrition—Sibutramine—obesity	0.000229	0.00195	CcSEcCtD
Erlotinib—Back pain—Orlistat—obesity	0.000229	0.00195	CcSEcCtD
Erlotinib—Urinary tract disorder—Bupropion—obesity	0.000227	0.00193	CcSEcCtD
Erlotinib—Flatulence—Sibutramine—obesity	0.000226	0.00192	CcSEcCtD
Erlotinib—Connective tissue disorder—Bupropion—obesity	0.000226	0.00192	CcSEcCtD
Erlotinib—CYP1B1—endocrine gland—obesity	0.000226	0.00325	CbGeAlD
Erlotinib—Urethral disorder—Bupropion—obesity	0.000225	0.00192	CcSEcCtD
Erlotinib—CYP2C8—pituitary gland—obesity	0.000223	0.00321	CbGeAlD
Erlotinib—Vomiting—Cimetidine—obesity	0.000223	0.0019	CcSEcCtD
Erlotinib—Back pain—Sibutramine—obesity	0.000222	0.00189	CcSEcCtD
Erlotinib—ALB—liver—obesity	0.000222	0.00319	CbGeAlD
Erlotinib—Rash—Cimetidine—obesity	0.000221	0.00188	CcSEcCtD
Erlotinib—Dermatitis—Cimetidine—obesity	0.000221	0.00188	CcSEcCtD
Erlotinib—Headache—Cimetidine—obesity	0.000219	0.00187	CcSEcCtD
Erlotinib—Nausea—Diethylpropion—obesity	0.000219	0.00186	CcSEcCtD
Erlotinib—Erythema multiforme—Bupropion—obesity	0.000217	0.00185	CcSEcCtD
Erlotinib—ABCG2—pituitary gland—obesity	0.000217	0.00312	CbGeAlD
Erlotinib—ABCG2—adipose tissue—obesity	0.000216	0.00311	CbGeAlD
Erlotinib—Eye disorder—Bupropion—obesity	0.000215	0.00183	CcSEcCtD
Erlotinib—Nausea—Cimetidine—obesity	0.000208	0.00177	CcSEcCtD
Erlotinib—Mediastinal disorder—Bupropion—obesity	0.000207	0.00176	CcSEcCtD
Erlotinib—Cough—Orlistat—obesity	0.000207	0.00176	CcSEcCtD
Erlotinib—Chills—Bupropion—obesity	0.000206	0.00175	CcSEcCtD
Erlotinib—Syncope—Sibutramine—obesity	0.000206	0.00175	CcSEcCtD
Erlotinib—Arrhythmia—Bupropion—obesity	0.000205	0.00175	CcSEcCtD
Erlotinib—CYP1A1—adipose tissue—obesity	0.000205	0.00295	CbGeAlD
Erlotinib—CYP1B1—liver—obesity	0.000203	0.00293	CbGeAlD
Erlotinib—Alopecia—Bupropion—obesity	0.000203	0.00173	CcSEcCtD
Erlotinib—Chest pain—Orlistat—obesity	0.000202	0.00172	CcSEcCtD
Erlotinib—Myalgia—Orlistat—obesity	0.000202	0.00172	CcSEcCtD
Erlotinib—Loss of consciousness—Sibutramine—obesity	0.000202	0.00172	CcSEcCtD
Erlotinib—Mental disorder—Bupropion—obesity	0.000201	0.00171	CcSEcCtD
Erlotinib—Anxiety—Orlistat—obesity	0.000201	0.00171	CcSEcCtD
Erlotinib—CYP3A5—adipose tissue—obesity	0.0002	0.00289	CbGeAlD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.0002	0.0017	CcSEcCtD
Erlotinib—Cough—Sibutramine—obesity	0.0002	0.0017	CcSEcCtD
Erlotinib—Malnutrition—Bupropion—obesity	0.0002	0.0017	CcSEcCtD
Erlotinib—Flatulence—Bupropion—obesity	0.000197	0.00168	CcSEcCtD
Erlotinib—Dehydration—Topiramate—obesity	0.000197	0.00167	CcSEcCtD
Erlotinib—CYP1A2—digestive system—obesity	0.000196	0.00282	CbGeAlD
Erlotinib—Myalgia—Sibutramine—obesity	0.000195	0.00166	CcSEcCtD
Erlotinib—Chest pain—Sibutramine—obesity	0.000195	0.00166	CcSEcCtD
Erlotinib—Arthralgia—Sibutramine—obesity	0.000195	0.00166	CcSEcCtD
Erlotinib—Anxiety—Sibutramine—obesity	0.000195	0.00166	CcSEcCtD
Erlotinib—ABCG2—adrenal gland—obesity	0.000194	0.00279	CbGeAlD
Erlotinib—Oedema—Orlistat—obesity	0.000193	0.00165	CcSEcCtD
Erlotinib—Back pain—Bupropion—obesity	0.000193	0.00165	CcSEcCtD
Erlotinib—CYP1A1—digestive system—obesity	0.000193	0.00278	CbGeAlD
Erlotinib—Hypokalaemia—Topiramate—obesity	0.000192	0.00164	CcSEcCtD
Erlotinib—Infection—Orlistat—obesity	0.000192	0.00164	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Topiramate—obesity	0.00019	0.00162	CcSEcCtD
Erlotinib—Nervous system disorder—Orlistat—obesity	0.00019	0.00161	CcSEcCtD
Erlotinib—CYP3A5—digestive system—obesity	0.000189	0.00272	CbGeAlD
Erlotinib—Skin disorder—Orlistat—obesity	0.000188	0.0016	CcSEcCtD
Erlotinib—Gastritis—Topiramate—obesity	0.000187	0.00159	CcSEcCtD
Erlotinib—Oedema—Sibutramine—obesity	0.000187	0.00159	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Topiramate—obesity	0.000187	0.00159	CcSEcCtD
Erlotinib—Infection—Sibutramine—obesity	0.000186	0.00158	CcSEcCtD
Erlotinib—Shock—Sibutramine—obesity	0.000184	0.00157	CcSEcCtD
Erlotinib—Thrombocytopenia—Sibutramine—obesity	0.000183	0.00156	CcSEcCtD
Erlotinib—Dysphagia—Topiramate—obesity	0.000183	0.00156	CcSEcCtD
Erlotinib—Skin disorder—Sibutramine—obesity	0.000182	0.00155	CcSEcCtD
Erlotinib—Syncope—Bupropion—obesity	0.000179	0.00153	CcSEcCtD
Erlotinib—Pancreatitis—Topiramate—obesity	0.000179	0.00153	CcSEcCtD
Erlotinib—Anorexia—Sibutramine—obesity	0.000178	0.00152	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Orlistat—obesity	0.000176	0.0015	CcSEcCtD
Erlotinib—Loss of consciousness—Bupropion—obesity	0.000176	0.0015	CcSEcCtD
Erlotinib—Insomnia—Orlistat—obesity	0.000175	0.00149	CcSEcCtD
Erlotinib—Cough—Bupropion—obesity	0.000174	0.00148	CcSEcCtD
Erlotinib—CYP2C8—endocrine gland—obesity	0.000173	0.00249	CbGeAlD
Erlotinib—Neutropenia—Topiramate—obesity	0.000171	0.00145	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Sibutramine—obesity	0.00017	0.00145	CcSEcCtD
Erlotinib—Dyspepsia—Orlistat—obesity	0.00017	0.00145	CcSEcCtD
Erlotinib—Chest pain—Bupropion—obesity	0.00017	0.00145	CcSEcCtD
Erlotinib—Arthralgia—Bupropion—obesity	0.00017	0.00145	CcSEcCtD
Erlotinib—Myalgia—Bupropion—obesity	0.00017	0.00145	CcSEcCtD
Erlotinib—Anxiety—Bupropion—obesity	0.00017	0.00144	CcSEcCtD
Erlotinib—Insomnia—Sibutramine—obesity	0.000169	0.00144	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000169	0.00144	CcSEcCtD
Erlotinib—Decreased appetite—Orlistat—obesity	0.000168	0.00143	CcSEcCtD
Erlotinib—ABCB1—islet of Langerhans—obesity	0.000167	0.00241	CbGeAlD
Erlotinib—Gastrointestinal disorder—Orlistat—obesity	0.000167	0.00142	CcSEcCtD
Erlotinib—Dyspnoea—Sibutramine—obesity	0.000167	0.00142	CcSEcCtD
Erlotinib—Fatigue—Orlistat—obesity	0.000167	0.00142	CcSEcCtD
Erlotinib—Weight decreased—Topiramate—obesity	0.000165	0.00141	CcSEcCtD
Erlotinib—Pain—Orlistat—obesity	0.000165	0.00141	CcSEcCtD
Erlotinib—Dyspepsia—Sibutramine—obesity	0.000165	0.0014	CcSEcCtD
Erlotinib—Pneumonia—Topiramate—obesity	0.000164	0.0014	CcSEcCtD
Erlotinib—Oedema—Bupropion—obesity	0.000163	0.00139	CcSEcCtD
Erlotinib—Infestation—Topiramate—obesity	0.000163	0.00139	CcSEcCtD
Erlotinib—Infestation NOS—Topiramate—obesity	0.000163	0.00139	CcSEcCtD
Erlotinib—Decreased appetite—Sibutramine—obesity	0.000163	0.00138	CcSEcCtD
Erlotinib—Depression—Topiramate—obesity	0.000162	0.00138	CcSEcCtD
Erlotinib—Infection—Bupropion—obesity	0.000162	0.00138	CcSEcCtD
Erlotinib—CYP1A2—endocrine gland—obesity	0.000162	0.00233	CbGeAlD
Erlotinib—Stevens-Johnson syndrome—Topiramate—obesity	0.000162	0.00138	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Sibutramine—obesity	0.000162	0.00138	CcSEcCtD
Erlotinib—Shock—Bupropion—obesity	0.00016	0.00137	CcSEcCtD
Erlotinib—Renal failure—Topiramate—obesity	0.00016	0.00136	CcSEcCtD
Erlotinib—Pain—Sibutramine—obesity	0.00016	0.00136	CcSEcCtD
Erlotinib—Constipation—Sibutramine—obesity	0.00016	0.00136	CcSEcCtD
Erlotinib—Nervous system disorder—Bupropion—obesity	0.00016	0.00136	CcSEcCtD
Erlotinib—Neuropathy peripheral—Topiramate—obesity	0.00016	0.00136	CcSEcCtD
Erlotinib—Thrombocytopenia—Bupropion—obesity	0.00016	0.00136	CcSEcCtD
Erlotinib—CYP1A1—endocrine gland—obesity	0.000159	0.0023	CbGeAlD
Erlotinib—Stomatitis—Topiramate—obesity	0.000159	0.00135	CcSEcCtD
Erlotinib—Skin disorder—Bupropion—obesity	0.000158	0.00135	CcSEcCtD
Erlotinib—Conjunctivitis—Topiramate—obesity	0.000158	0.00135	CcSEcCtD
Erlotinib—Gastrointestinal pain—Orlistat—obesity	0.000158	0.00135	CcSEcCtD
Erlotinib—ABCB1—respiratory system—obesity	0.000158	0.00227	CbGeAlD
Erlotinib—CYP3A5—endocrine gland—obesity	0.000156	0.00225	CbGeAlD
Erlotinib—CYP2C8—liver—obesity	0.000156	0.00224	CbGeAlD
Erlotinib—Anorexia—Bupropion—obesity	0.000155	0.00132	CcSEcCtD
Erlotinib—Epistaxis—Topiramate—obesity	0.000154	0.00131	CcSEcCtD
Erlotinib—Gastrointestinal pain—Sibutramine—obesity	0.000153	0.0013	CcSEcCtD
Erlotinib—Abdominal pain—Orlistat—obesity	0.000153	0.0013	CcSEcCtD
Erlotinib—Body temperature increased—Orlistat—obesity	0.000153	0.0013	CcSEcCtD
Erlotinib—ABCG2—liver—obesity	0.000151	0.00218	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Bupropion—obesity	0.000149	0.00127	CcSEcCtD
Erlotinib—Abdominal pain—Sibutramine—obesity	0.000148	0.00126	CcSEcCtD
Erlotinib—Body temperature increased—Sibutramine—obesity	0.000148	0.00126	CcSEcCtD
Erlotinib—Insomnia—Bupropion—obesity	0.000148	0.00126	CcSEcCtD
Erlotinib—Haemoglobin—Topiramate—obesity	0.000147	0.00125	CcSEcCtD
Erlotinib—Haemorrhage—Topiramate—obesity	0.000146	0.00125	CcSEcCtD
Erlotinib—Hepatitis—Topiramate—obesity	0.000146	0.00125	CcSEcCtD
Erlotinib—CYP1A2—liver—obesity	0.000146	0.0021	CbGeAlD
Erlotinib—Dyspnoea—Bupropion—obesity	0.000145	0.00124	CcSEcCtD
Erlotinib—Urinary tract disorder—Topiramate—obesity	0.000144	0.00123	CcSEcCtD
Erlotinib—Connective tissue disorder—Topiramate—obesity	0.000144	0.00122	CcSEcCtD
Erlotinib—CYP1A1—liver—obesity	0.000144	0.00207	CbGeAlD
Erlotinib—Dyspepsia—Bupropion—obesity	0.000144	0.00122	CcSEcCtD
Erlotinib—Urethral disorder—Topiramate—obesity	0.000143	0.00122	CcSEcCtD
Erlotinib—Decreased appetite—Bupropion—obesity	0.000142	0.00121	CcSEcCtD
Erlotinib—CYP3A4—digestive system—obesity	0.000142	0.00204	CbGeAlD
Erlotinib—Gastrointestinal disorder—Bupropion—obesity	0.000141	0.0012	CcSEcCtD
Erlotinib—Fatigue—Bupropion—obesity	0.000141	0.0012	CcSEcCtD
Erlotinib—CYP3A5—liver—obesity	0.000141	0.00203	CbGeAlD
Erlotinib—Constipation—Bupropion—obesity	0.00014	0.00119	CcSEcCtD
Erlotinib—Pain—Bupropion—obesity	0.00014	0.00119	CcSEcCtD
Erlotinib—CYP2D6—digestive system—obesity	0.000139	0.00201	CbGeAlD
Erlotinib—Asthenia—Orlistat—obesity	0.000139	0.00118	CcSEcCtD
Erlotinib—Erythema multiforme—Topiramate—obesity	0.000138	0.00118	CcSEcCtD
Erlotinib—Pruritus—Orlistat—obesity	0.000137	0.00116	CcSEcCtD
Erlotinib—Eye disorder—Topiramate—obesity	0.000137	0.00116	CcSEcCtD
Erlotinib—Asthenia—Sibutramine—obesity	0.000134	0.00114	CcSEcCtD
Erlotinib—Gastrointestinal pain—Bupropion—obesity	0.000133	0.00114	CcSEcCtD
Erlotinib—Pruritus—Sibutramine—obesity	0.000132	0.00113	CcSEcCtD
Erlotinib—ABCB1—adrenal cortex—obesity	0.000132	0.00191	CbGeAlD
Erlotinib—Diarrhoea—Orlistat—obesity	0.000132	0.00113	CcSEcCtD
Erlotinib—Mediastinal disorder—Topiramate—obesity	0.000132	0.00112	CcSEcCtD
Erlotinib—Chills—Topiramate—obesity	0.000131	0.00112	CcSEcCtD
Erlotinib—Alopecia—Topiramate—obesity	0.000129	0.0011	CcSEcCtD
Erlotinib—Body temperature increased—Bupropion—obesity	0.000129	0.0011	CcSEcCtD
Erlotinib—Abdominal pain—Bupropion—obesity	0.000129	0.0011	CcSEcCtD
Erlotinib—Mental disorder—Topiramate—obesity	0.000128	0.00109	CcSEcCtD
Erlotinib—Diarrhoea—Sibutramine—obesity	0.000128	0.00109	CcSEcCtD
Erlotinib—Dizziness—Orlistat—obesity	0.000128	0.00109	CcSEcCtD
Erlotinib—Erythema—Topiramate—obesity	0.000127	0.00108	CcSEcCtD
Erlotinib—Malnutrition—Topiramate—obesity	0.000127	0.00108	CcSEcCtD
Erlotinib—Flatulence—Topiramate—obesity	0.000125	0.00107	CcSEcCtD
Erlotinib—Dizziness—Sibutramine—obesity	0.000124	0.00105	CcSEcCtD
Erlotinib—Back pain—Topiramate—obesity	0.000123	0.00105	CcSEcCtD
Erlotinib—Vomiting—Orlistat—obesity	0.000123	0.00105	CcSEcCtD
Erlotinib—Rash—Orlistat—obesity	0.000122	0.00104	CcSEcCtD
Erlotinib—Dermatitis—Orlistat—obesity	0.000122	0.00104	CcSEcCtD
Erlotinib—Headache—Orlistat—obesity	0.000121	0.00103	CcSEcCtD
Erlotinib—ABCB1—cardiovascular system—obesity	0.000121	0.00174	CbGeAlD
Erlotinib—Vomiting—Sibutramine—obesity	0.000119	0.00101	CcSEcCtD
Erlotinib—Rash—Sibutramine—obesity	0.000118	0.001	CcSEcCtD
Erlotinib—Dermatitis—Sibutramine—obesity	0.000118	0.001	CcSEcCtD
Erlotinib—Headache—Sibutramine—obesity	0.000117	0.000998	CcSEcCtD
Erlotinib—Asthenia—Bupropion—obesity	0.000117	0.000996	CcSEcCtD
Erlotinib—CYP3A4—endocrine gland—obesity	0.000117	0.00169	CbGeAlD
Erlotinib—Pruritus—Bupropion—obesity	0.000115	0.000982	CcSEcCtD
Erlotinib—CYP2D6—endocrine gland—obesity	0.000115	0.00166	CbGeAlD
Erlotinib—Nausea—Orlistat—obesity	0.000115	0.000978	CcSEcCtD
Erlotinib—Syncope—Topiramate—obesity	0.000114	0.000972	CcSEcCtD
Erlotinib—Loss of consciousness—Topiramate—obesity	0.000112	0.000953	CcSEcCtD
Erlotinib—Diarrhoea—Bupropion—obesity	0.000112	0.00095	CcSEcCtD
Erlotinib—Nausea—Sibutramine—obesity	0.000111	0.000946	CcSEcCtD
Erlotinib—Cough—Topiramate—obesity	0.000111	0.000946	CcSEcCtD
Erlotinib—Chest pain—Topiramate—obesity	0.000108	0.000923	CcSEcCtD
Erlotinib—Arthralgia—Topiramate—obesity	0.000108	0.000923	CcSEcCtD
Erlotinib—Myalgia—Topiramate—obesity	0.000108	0.000923	CcSEcCtD
Erlotinib—Anxiety—Topiramate—obesity	0.000108	0.00092	CcSEcCtD
Erlotinib—Dizziness—Bupropion—obesity	0.000108	0.000918	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000108	0.000916	CcSEcCtD
Erlotinib—ABCB1—pituitary gland—obesity	0.000107	0.00154	CbGeAlD
Erlotinib—ABCB1—adipose tissue—obesity	0.000106	0.00153	CbGeAlD
Erlotinib—CYP3A4—liver—obesity	0.000105	0.00152	CbGeAlD
Erlotinib—Oedema—Topiramate—obesity	0.000104	0.000885	CcSEcCtD
Erlotinib—CYP2D6—liver—obesity	0.000104	0.0015	CbGeAlD
Erlotinib—Vomiting—Bupropion—obesity	0.000104	0.000883	CcSEcCtD
Erlotinib—Infection—Topiramate—obesity	0.000103	0.000879	CcSEcCtD
Erlotinib—Rash—Bupropion—obesity	0.000103	0.000875	CcSEcCtD
Erlotinib—Dermatitis—Bupropion—obesity	0.000103	0.000875	CcSEcCtD
Erlotinib—Shock—Topiramate—obesity	0.000102	0.00087	CcSEcCtD
Erlotinib—Headache—Bupropion—obesity	0.000102	0.00087	CcSEcCtD
Erlotinib—Nervous system disorder—Topiramate—obesity	0.000102	0.000868	CcSEcCtD
Erlotinib—Thrombocytopenia—Topiramate—obesity	0.000102	0.000866	CcSEcCtD
Erlotinib—Skin disorder—Topiramate—obesity	0.000101	0.000859	CcSEcCtD
Erlotinib—ABCB1—digestive system—obesity	0.0001	0.00144	CbGeAlD
Erlotinib—Anorexia—Topiramate—obesity	9.91e-05	0.000843	CcSEcCtD
Erlotinib—Nausea—Bupropion—obesity	9.69e-05	0.000825	CcSEcCtD
Erlotinib—ABCB1—adrenal gland—obesity	9.55e-05	0.00138	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Topiramate—obesity	9.47e-05	0.000806	CcSEcCtD
Erlotinib—Insomnia—Topiramate—obesity	9.4e-05	0.0008	CcSEcCtD
Erlotinib—Dyspnoea—Topiramate—obesity	9.27e-05	0.000789	CcSEcCtD
Erlotinib—Dyspepsia—Topiramate—obesity	9.15e-05	0.000779	CcSEcCtD
Erlotinib—Decreased appetite—Topiramate—obesity	9.03e-05	0.000769	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Topiramate—obesity	8.97e-05	0.000764	CcSEcCtD
Erlotinib—Fatigue—Topiramate—obesity	8.96e-05	0.000763	CcSEcCtD
Erlotinib—Constipation—Topiramate—obesity	8.89e-05	0.000756	CcSEcCtD
Erlotinib—Pain—Topiramate—obesity	8.89e-05	0.000756	CcSEcCtD
Erlotinib—Gastrointestinal pain—Topiramate—obesity	8.5e-05	0.000723	CcSEcCtD
Erlotinib—ABCB1—endocrine gland—obesity	8.28e-05	0.00119	CbGeAlD
Erlotinib—Body temperature increased—Topiramate—obesity	8.22e-05	0.000699	CcSEcCtD
Erlotinib—Abdominal pain—Topiramate—obesity	8.22e-05	0.000699	CcSEcCtD
Erlotinib—ABCB1—liver—obesity	7.47e-05	0.00108	CbGeAlD
Erlotinib—Asthenia—Topiramate—obesity	7.46e-05	0.000635	CcSEcCtD
Erlotinib—Pruritus—Topiramate—obesity	7.35e-05	0.000626	CcSEcCtD
Erlotinib—Diarrhoea—Topiramate—obesity	7.11e-05	0.000605	CcSEcCtD
Erlotinib—Dizziness—Topiramate—obesity	6.87e-05	0.000585	CcSEcCtD
Erlotinib—Vomiting—Topiramate—obesity	6.61e-05	0.000562	CcSEcCtD
Erlotinib—Rash—Topiramate—obesity	6.55e-05	0.000558	CcSEcCtD
Erlotinib—Dermatitis—Topiramate—obesity	6.55e-05	0.000557	CcSEcCtD
Erlotinib—Headache—Topiramate—obesity	6.51e-05	0.000554	CcSEcCtD
Erlotinib—Nausea—Topiramate—obesity	6.17e-05	0.000525	CcSEcCtD
Erlotinib—ALB—Metabolism—CD36—obesity	1.68e-06	1.32e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2E1—obesity	1.66e-06	1.3e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PRKAR2B—obesity	1.66e-06	1.3e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PIK3CB—obesity	1.66e-06	1.3e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AGT—obesity	1.66e-06	1.3e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GNAS—obesity	1.66e-06	1.3e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DCN—obesity	1.65e-06	1.29e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—obesity	1.65e-06	1.29e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NQO1—obesity	1.64e-06	1.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TYK2—obesity	1.64e-06	1.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—STAT3—obesity	1.64e-06	1.29e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—PIK3CA—obesity	1.64e-06	1.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RHOA—obesity	1.63e-06	1.28e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—COMT—obesity	1.63e-06	1.27e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—obesity	1.63e-06	1.27e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOB—obesity	1.62e-06	1.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—obesity	1.61e-06	1.26e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PIK3R1—obesity	1.61e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAV1—obesity	1.61e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.61e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOA1—obesity	1.61e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CPT1A—obesity	1.61e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GNB3—obesity	1.6e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARGC1A—obesity	1.6e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—obesity	1.6e-06	1.25e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HMOX1—obesity	1.6e-06	1.25e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.6e-06	1.25e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—obesity	1.59e-06	1.25e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GCG—obesity	1.58e-06	1.23e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC2A4—obesity	1.58e-06	1.23e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NAMPT—obesity	1.57e-06	1.23e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARA—obesity	1.57e-06	1.23e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LIPC—obesity	1.56e-06	1.22e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCK—obesity	1.56e-06	1.22e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARA—obesity	1.56e-06	1.22e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GNAS—obesity	1.56e-06	1.22e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYCS—obesity	1.56e-06	1.22e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOC3—obesity	1.55e-06	1.22e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3CG—obesity	1.55e-06	1.22e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LPL—obesity	1.55e-06	1.21e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—PIK3CA—obesity	1.54e-06	1.21e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.54e-06	1.21e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—PIK3CA—obesity	1.54e-06	1.2e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOB—obesity	1.53e-06	1.2e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT1—obesity	1.53e-06	1.2e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT1—obesity	1.53e-06	1.2e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—MYC—obesity	1.53e-06	1.19e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—obesity	1.52e-06	1.19e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AGT—obesity	1.52e-06	1.19e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AGT—obesity	1.51e-06	1.18e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GPX1—obesity	1.51e-06	1.18e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CETP—obesity	1.51e-06	1.18e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NCOA1—obesity	1.5e-06	1.18e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—obesity	1.5e-06	1.17e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—obesity	1.5e-06	1.17e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SDC1—obesity	1.49e-06	1.17e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—obesity	1.49e-06	1.17e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PIK3CB—obesity	1.49e-06	1.16e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MTOR—obesity	1.49e-06	1.16e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—obesity	1.48e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP19A1—obesity	1.48e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—STK11—obesity	1.48e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—obesity	1.48e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAV1—obesity	1.48e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOA1—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CD36—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—INS—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAV1—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AKR1C3—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3CG—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOA1—obesity	1.47e-06	1.15e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LPL—obesity	1.46e-06	1.14e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—obesity	1.45e-06	1.14e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SCARB1—obesity	1.45e-06	1.13e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GPX1—obesity	1.42e-06	1.12e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—obesity	1.42e-06	1.11e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.41e-06	1.1e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.4e-06	1.1e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SREBF1—obesity	1.4e-06	1.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—PIK3CA—obesity	1.4e-06	1.1e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—obesity	1.4e-06	1.09e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—obesity	1.39e-06	1.09e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—INS—obesity	1.39e-06	1.09e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CD36—obesity	1.39e-06	1.09e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AKT1—obesity	1.38e-06	1.08e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—COMT—obesity	1.38e-06	1.08e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARA—obesity	1.37e-06	1.07e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3CD—obesity	1.37e-06	1.07e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT2—obesity	1.36e-06	1.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—obesity	1.36e-06	1.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GNB3—obesity	1.36e-06	1.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARGC1A—obesity	1.36e-06	1.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HMOX1—obesity	1.35e-06	1.06e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—obesity	1.35e-06	1.06e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3CG—obesity	1.35e-06	1.05e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—AKT1—obesity	1.34e-06	1.05e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3CG—obesity	1.34e-06	1.05e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—FASN—obesity	1.34e-06	1.05e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—BCHE—obesity	1.33e-06	1.04e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AGT—obesity	1.33e-06	1.04e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GNAS—obesity	1.32e-06	1.04e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—obesity	1.31e-06	1.03e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—obesity	1.3e-06	1.02e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—obesity	1.3e-06	1.02e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOB—obesity	1.3e-06	1.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PIK3CA—obesity	1.3e-06	1.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3CD—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARA—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3R1—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAV1—obesity	1.29e-06	1.01e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOA1—obesity	1.28e-06	1.01e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2E1—obesity	1.28e-06	1e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—obesity	1.28e-06	1e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—INS—obesity	1.27e-06	9.97e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—obesity	1.27e-06	9.97e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—obesity	1.27e-06	9.97e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NQO1—obesity	1.27e-06	9.93e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—INS—obesity	1.27e-06	9.91e-06	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—AKT1—obesity	1.26e-06	9.86e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MAPK8—obesity	1.26e-06	9.85e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AKT1—obesity	1.25e-06	9.82e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AGT—obesity	1.25e-06	9.78e-06	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—obesity	1.24e-06	9.73e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LPL—obesity	1.24e-06	9.68e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—obesity	1.22e-06	9.58e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—obesity	1.22e-06	9.54e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3R1—obesity	1.22e-06	9.54e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC2A4—obesity	1.22e-06	9.52e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCG—obesity	1.22e-06	9.52e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAV1—obesity	1.21e-06	9.49e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOA1—obesity	1.21e-06	9.47e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GPX1—obesity	1.21e-06	9.45e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYCS—obesity	1.2e-06	9.4e-06	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PIK3CA—obesity	1.19e-06	9.34e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3CB—obesity	1.19e-06	9.32e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3CD—obesity	1.18e-06	9.26e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—obesity	1.18e-06	9.23e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT1—obesity	1.18e-06	9.22e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT1—obesity	1.18e-06	9.22e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3CD—obesity	1.18e-06	9.21e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CD36—obesity	1.18e-06	9.2e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3CG—obesity	1.17e-06	9.18e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—obesity	1.17e-06	9.14e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NCOA1—obesity	1.16e-06	9.09e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—STAT3—obesity	1.15e-06	9e-06	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—obesity	1.15e-06	8.98e-06	CbGpPWpGaD
Erlotinib—EGFR—Immune System—AKT1—obesity	1.15e-06	8.97e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—STK11—obesity	1.14e-06	8.95e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP19A1—obesity	1.14e-06	8.95e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—obesity	1.13e-06	8.86e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3CB—obesity	1.12e-06	8.8e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3R1—obesity	1.12e-06	8.74e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—obesity	1.12e-06	8.74e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—obesity	1.12e-06	8.74e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—obesity	1.11e-06	8.72e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—obesity	1.11e-06	8.72e-06	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PIK3CA—obesity	1.11e-06	8.71e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3R1—obesity	1.11e-06	8.69e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—obesity	1.11e-06	8.69e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—INS—obesity	1.11e-06	8.69e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3CG—obesity	1.1e-06	8.65e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARA—obesity	1.09e-06	8.55e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MYC—obesity	1.07e-06	8.37e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—obesity	1.07e-06	8.35e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—obesity	1.07e-06	8.34e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—COMT—obesity	1.06e-06	8.32e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AGT—obesity	1.06e-06	8.28e-06	CbGpPWpGaD
Erlotinib—EGFR—Disease—AKT1—obesity	1.06e-06	8.28e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—obesity	1.05e-06	8.23e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARGC1A—obesity	1.05e-06	8.21e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GNB3—obesity	1.05e-06	8.21e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—INS—obesity	1.05e-06	8.19e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMOX1—obesity	1.04e-06	8.17e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—obesity	1.04e-06	8.12e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3CB—obesity	1.03e-06	8.07e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3CD—obesity	1.03e-06	8.07e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAV1—obesity	1.03e-06	8.04e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3CB—obesity	1.02e-06	8.03e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOA1—obesity	1.02e-06	8.02e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—obesity	1.02e-06	8e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GNAS—obesity	1.02e-06	7.99e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—obesity	1.02e-06	7.96e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—obesity	1.02e-06	7.95e-06	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PIK3CA—obesity	1.01e-06	7.93e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOB—obesity	1e-06	7.83e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.81e-07	7.68e-06	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AKT1—obesity	9.75e-07	7.63e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3R1—obesity	9.73e-07	7.62e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—obesity	9.73e-07	7.62e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3CD—obesity	9.71e-07	7.6e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—obesity	9.58e-07	7.5e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPL—obesity	9.55e-07	7.47e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3CG—obesity	9.36e-07	7.33e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GPX1—obesity	9.31e-07	7.29e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—obesity	9.17e-07	7.18e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3R1—obesity	9.17e-07	7.18e-06	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AKT1—obesity	9.09e-07	7.12e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CD36—obesity	9.07e-07	7.1e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PIK3CA—obesity	9.07e-07	7.1e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—obesity	9.03e-07	7.07e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3CB—obesity	8.98e-07	7.03e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—obesity	8.91e-07	6.97e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—obesity	8.9e-07	6.97e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—INS—obesity	8.86e-07	6.93e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—obesity	8.59e-07	6.73e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3CB—obesity	8.46e-07	6.63e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARA—obesity	8.43e-07	6.6e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—obesity	8.39e-07	6.57e-06	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AKT1—obesity	8.27e-07	6.48e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3CD—obesity	8.23e-07	6.44e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AGT—obesity	8.17e-07	6.39e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—obesity	8.12e-07	6.36e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—obesity	8.03e-07	6.29e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—obesity	8e-07	6.26e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAV1—obesity	7.93e-07	6.21e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOA1—obesity	7.91e-07	6.19e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—obesity	7.77e-07	6.08e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3R1—obesity	7.77e-07	6.08e-06	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AKT1—obesity	7.41e-07	5.8e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3CA—obesity	7.26e-07	5.68e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3CG—obesity	7.22e-07	5.65e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3CB—obesity	7.17e-07	5.61e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—obesity	7.1e-07	5.56e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—obesity	6.97e-07	5.46e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—obesity	6.87e-07	5.38e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3CA—obesity	6.85e-07	5.37e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—INS—obesity	6.84e-07	5.35e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3CD—obesity	6.35e-07	4.97e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3CA—obesity	6.28e-07	4.92e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—obesity	6.27e-07	4.91e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3CA—obesity	6.25e-07	4.89e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3R1—obesity	5.99e-07	4.69e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—obesity	5.99e-07	4.69e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AKT1—obesity	5.93e-07	4.64e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AKT1—obesity	5.6e-07	4.38e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3CB—obesity	5.53e-07	4.33e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—obesity	5.48e-07	4.29e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3CA—obesity	5.47e-07	4.29e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3CA—obesity	5.16e-07	4.04e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AKT1—obesity	5.13e-07	4.02e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AKT1—obesity	5.1e-07	4e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AKT1—obesity	4.47e-07	3.5e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3CA—obesity	4.37e-07	3.42e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AKT1—obesity	4.21e-07	3.3e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AKT1—obesity	3.57e-07	2.8e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3CA—obesity	3.37e-07	2.64e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AKT1—obesity	2.76e-07	2.16e-06	CbGpPWpGaD
